Hikma Pharmaceuticals PLC
HIKHealthcare
£12.79-0.62%
Key Metrics
Market Cap
£2.8B
P/E Ratio
9.3
P/B Ratio
143.8
Div Yield
4.8%
EPS
£0.0
Profit Margin
12.0%
Beta
0.7
52w Range
£11.87 – £21.64
About Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products. The company operates through three segments: Injectables, Hikma Rx, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The Hikma Rx segment offers oral, respiratory, and other generic and speci
Sector Peers (Healthcare)
Data sourced from Yahoo Finance. Prices in GBP. Updated at build time. This is not financial advice — see our disclaimer.